Category: by publisher

Science flags immune-boosting paper under investigation

F1.mediumScience magazine has issued an expression of concern for a paper on the discovery of a new immune-boosting protein. The paper’s findings, which received some press coverage when they came out last spring, are now under investigation by Imperial College London.

The expression of concern follows a correction noting a Western blot mix-up. Science Editor in Chief Marcia McNutt told us last month that the mistake resulted from “carelessness” on the part of the authors. But now, an investigation at Imperial College London — where Philip Ashton-Rickardt led the research — is formally looking into the findings.

That investigation is ongoing, according to the expression of concern (signed by McNutt):

Continue reading Science flags immune-boosting paper under investigation

Author added to paper after investigation at University of Helsinki

CoverIssueAn author has been added to a biochemistry paper following an investigation by the University of Helsinki.

Karen Sabatini, currently a biochemist at the University of San Diego, was erroneously left off the author list of a paper published in 2010 in Soft Matter. She apparently left Helsinki in 2010.

The circumstances may be unclear, but one thing we do know: authorship issues often take down papers entirely. Since this just warranted a correction, the mistake could have just been an oversight, rather than pointing to a larger issue.

Here’s the note for “Formation of lipid/peptide tubules by IAPP and temporin B on supported lipid membranes:”

Continue reading Author added to paper after investigation at University of Helsinki

Science retracts physics paper after magnetic field wasn’t what it seemed

F1.mediumScience has retracted an August paper on an interesting electric current researchers observed in a kind of material called a topological insulator. Well, a current the researchers — based at Stanford and MIT — thought they had observed.

A magnetic field with particular attributes reported in the paper seemed to provide evidence of the current. But the researchers soon discovered that the field might have been, in part, an artifact of the very device they used to detect it. The authors, along with a few other researchers, have published that subsequent finding on the physics preprint server, arXiv.

Here’s the retraction note:
Continue reading Science retracts physics paper after magnetic field wasn’t what it seemed

Critics of 2008 concussion study failed to note NFL ties

Jama neurWhen a 2008 paper proposed that athletes be kept out of play for four weeks following a concussion, three doctors wrote in to say that the recommendations were “irrelevant and ill advised.” One thing the trio failed to disclose, however, was their own financial ties to the National Football League.

With the release of the 2013 Frontline documentary “League of Denial: The NFL’s Concussion Crisis” and the publication of Concussion by journalist Jeanne-Marie Laskas, the evidence is growing that the NFL — with the help of doctors working as paid consultants or expert witnesses for the NFL or individual teams  — has downplayed the potential of football to cause long-term brain injuries.

In a 2008, Lester Mayers of Pace University in Pleasantville, New York, published a review paper in Archives of Neurology (now JAMA Neurology), that summarized evidence from tests such as balance and gait testing, along with MRI and PET imaging studies. Mayers, who is now deceased, concluded in “Return-to-Play Criteria After Athletic Concussion: A Need for Revision” that it takes at least four weeks — rather than one or two — for the brain to heal following a concussion:

Continue reading Critics of 2008 concussion study failed to note NFL ties

In more faked peer review news…10 papers pulled by Hindawi

Screen Shot 2015-12-18 at 9.57.36 AMGuess what? We’ve got more cases of fraudulent peer review to report — our second post of the day on the subject, in fact. In the latest news, Hindawi Publishing Corporation has retracted 10 papers for “fraudulent review reports,” after an investigation of more than 30 papers that had been flagged this summer.

The investigation found that author Jason Jung, a computer engineer at Yeungnam University in Korea, “was involved in submitting the fraudulent review reports” for four of the retracted papers, according to the publisher’s CEO. In the case of the other six, the authors didn’t appear to be involved.

Hindawi Publishing Corporation, which publishes over 400 journals, doesn’t ask authors for potential review suggestions — making a common route to fake peer review more difficult.  In July, when Hindawi announced it was investigating the papers, it posted a statement saying that they suspected the editors had created fake reviewer accounts.

The retraction note on Jung’s papers — identical except for the title at the beginning — explains that each paper has

Continue reading In more faked peer review news…10 papers pulled by Hindawi

“Compromised” peer review hits three papers from Nature Publishing Group

company-info-big

Nature Publishing Group is retracting three papers today, after an investigation found evidence the peer-review process had been compromised.

The publisher issued a statement saying they had notified corresponding authors and institutions associated with the three papers, which were all published last year in the journals Cancer Gene Therapy and Spinal Cord. 

Here’s the note that’s going on each of the papers, (they’re the same, except for the publication date):

Continue reading “Compromised” peer review hits three papers from Nature Publishing Group

E. coli gene paper falls to mistaken mutation

asmcoverResearchers in Germany have retracted their 2011 article in the Journal of Bacteriology after another lab pointed out a fatal error in the paper.

The article, “Escherichia coli Exports Cyclic AMP via TolC,” came from a group at Tübingen University led by Klaus Hantke. The paper focuses on the crucial role of the membrane channel TolC in exporting cyclic AMP (cAMP)-cAMP receptor protein (CRP) complex, which regulates nearly 200 E. coli genes. According to the abstract:

The data demonstrate that export of cAMP via TolC is a most efficient way of E. coli to lower high concentrations of cAMP in the cell and maintain its sensitivity in changing metabolic environments.

But the conclusions rested on a gene mutation that wasn’t quite what it seemed. Here’s the notice: Continue reading E. coli gene paper falls to mistaken mutation

Fifth retraction for Wayne State researcher who fudged figures

teresita
Teresita L. Briones

Another retraction has appeared for Teresita Briones, who used to study neuroscience at Wayne State University — the final of five papers flagged by the Office of Research Integrity for containing falsified data.

According to the ORI notice published in May, Briones “intentionally, knowingly, and recklessly engaged in research misconduct by falsifying and/or fabricating data.” This latest paper to be retracted, which looks at the role of specific receptor in chronic inflammation of nervous tissue in rats, has two figures that “were duplicated, reused and falsely relabelled, and claimed to represent different experiments,” according to the retraction note.

The retraction note for “Chronic neuroinflammation and cognitive impairment following transient global cerebral ischemia: role of fractalkine/CX3CR1 signaling,” published in the Journal of Neuroinflammation, specifies the problematic figures:

Continue reading Fifth retraction for Wayne State researcher who fudged figures

“The peer review process was compromised”: Inflammation drug paper pulled

12

A paper that screened for antibodies that target TNFα, a major source of inflammation, has been retraction after an investigation revealed the peer-review process may have been compromised.

We’ve seen the peer review process “compromised” in a handful of ways — from a mathematician who oversaw the process on several of his own papers, to some 250 papers subject to outright fake peer review. The note for this paper, published in Amino Acids, doesn’t go into details, so we can only wonder what happened in this particular case.

Here’s the note for “Structure‑based development and optimization of therapy antibody drugs against TNFα:”

Continue reading “The peer review process was compromised”: Inflammation drug paper pulled

Authors retract abstract following misconduct by diabetes biotech

1Earlier this year, authors retracted a meeting abstract about a diabetes drug, following the revelation that the biotech that funded the trial committed misconduct.

The retraction was initiated by corresponding author Itamar Raz, at Hadassah Medical Center in Israel. The journal didn’t receive a response from any co-authors who were affiliated with the biotech company, Andromeda, so they were not included in the retraction process.

A few months after Hyperion Therapeutics acquired Andromeda’s diabetes drug DiaPep277, Hyperion announced it had evidence that some employees of Andromeda had “engaged in serious misconduct,” such as using un-blinded data and manipulating the analyses. Two relevant studies on the drug, designed to block the immune response that leads to type 1 diabetes, were retracted last year.

Here’s the retraction note for the abstract “Abstracts of the 50th Annual Meeting of the EASD, Vienna 2014. ‘Evaluation of DiaPep277® treatment in type 1 diabetes by integrated analysis,’” published in the May issue of the journal:

Continue reading Authors retract abstract following misconduct by diabetes biotech